Payoneer: Solid Moat With Strong Industry Tailwinds

Posted Apr 18 by Two Blokes

I am positive on Payoneer due to its strong global payment infrastructure, which subscale players will struggl

Source: Two Blokes Trading

Schlumberger (SLB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Posted Apr 18 by Two Blokes

Schlumberger (SLB) possesses the right combination of the two key ingredients for a likely earnings beat in it

Source: Two Blokes Trading

Italy agrees with US to oppose 'discriminatory' tech taxes

Posted Apr 18 by Two Blokes

Italy and the United States issued a joint statement against "discriminatory" taxes on digital services on Fri

Source: Two Blokes Trading

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zynex, Inc. of Class Action Lawsuit and

Posted Apr 18 by Two Blokes

NEW YORK, NY / ACCESS Newswire / April 18, 2025 / Pomerantz LLP announces that a class action lawsuit has been

Source: Two Blokes Trading

Dupixent\u00ae (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urtic

Posted Apr 18 by Two Blokes

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to place

Source: Two Blokes Trading

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in The Bancorp, Inc. of Class Action Lawsui

Posted Apr 18 by Two Blokes

NEW YORK, NY / ACCESS Newswire / April 18, 2025 / Pomerantz LLP announces that a class action lawsuit has been

Source: Two Blokes Trading

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Perpetua Resources Corp. of Class Action

Posted Apr 18 by Two Blokes

NEW YORK, NY / ACCESS Newswire / April 18, 2025 / Pomerantz LLP announces that a class action lawsuit has been

Source: Two Blokes Trading

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Posted Apr 18 by Two Blokes

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticar

Source: Two Blokes Trading

Levi & Korsinsky Reminds Ready Capital Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline

Posted Apr 18 by Two Blokes

NEW YORK, NY / ACCESS Newswire / April 18, 2025 / If you suffered a loss on your Ready Capital Corporation (NY

Source: Two Blokes Trading

Apple buying frenzy ahead of tariff pause raises eyebrows — but Letitia James only has blinders for Trump

Posted Apr 18 by Two Blokes

The NY AG, it should be noted, has been trying to nail Trump on something for years, she even campaigned on it

Source: Two Blokes Trading

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Open Lending

Posted Apr 18 by Two Blokes

Faruqi & Faruqi, LLP Securities Litigation Partner  James (Josh) Wilson Encourages Investors Who Suffered Sign

Source: Two Blokes Trading

Earnings Preview: Lazard (LAZ) Q1 Earnings Expected to Decline

Posted Apr 18 by Two Blokes

Lazard (LAZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in it

Source: Two Blokes Trading